Skip to main content

. 1974 Sep;67(9):847–849. doi: 10.1177/003591577406700912

Factors in tumour dissemination.

PMCID: PMC1645906 PMID: 4431792

847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Currie G. A., Bagshawe K. D. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer. 1969 Mar;23(1):141–149. doi: 10.1038/bjc.1969.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
Ferin M., Zimmering P. E., Lieberman S., Vande Wiele R. L. Inactivation of the biological effects of exogenous and endogenous estrogens by antibodies to 17-beta-estradiol. Endocrinology. 1968 Sep;83(3):565–571. doi: 10.1210/endo-83-3-565. [DOI] [PubMed] [Google Scholar]
Hellmann K. Effect of ICRF 159 on immune responses. Proc R Soc Med. 1972 Mar;65(3):264–265. doi: 10.1177/003591577206500317. [DOI] [PMC free article] [PubMed] [Google Scholar]
ROBERTSON D. M., WILLIAMS D. C. THE EFFECT OF TRANSPLANTED MAMMARY TUMOURS ON THE CALCIUM BALANCE OF THE RAT. Biochem Pharmacol. 1964 Jul;13:955–962. doi: 10.1016/0006-2952(64)90091-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES